p53 in human embryonal carcinoma: Identification of a transferable, transcriptional repression domain in the N-terminal region of p53

Oncogene

Volumn 24, Issue 9, 2005, Pages 1481-1490

  Curtin, Joshua C ^a   Spinella, Michael J ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Embryonal carcinoma; p53; Repression; Retinoic acid

Indexed keywords

DNA; HISTONE DEACETYLASE INHIBITOR; PROTEIN P53; RETINOIC ACID; RETINOIC ACID RECEPTOR GAMMA; TRICHOSTATIN A;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE DELETION; GENETIC TRANSFECTION; GERM CELL TUMOR; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; WILD TYPE; ANIMAL; BREAST TUMOR; CELL DIVISION; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; CHO CELL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HAMSTER; MOLECULAR GENETICS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CARCINOMA, EMBRYONAL; CELL DIVISION; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; TRANSCRIPTION, GENETIC; TRANSFECTION; TRETINOIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14944343862     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208130     Document Type: Article

References (59)

1. Andrews PW. (1984). Dev. Biol., 103, 285-293.
2. Andrews PW. (2002). Philos. Trans. R. Soc. London. B. Biol. Sci., 357, 405-417.
3. Bargonetti J, Manfredi JJ, Chen X, Marshak DR and Prives C. (1993). Genes Dev., 7, 2565-2574.
4. Benard J, Douc-Rasy S and Ahomadegbe J. (2003). Hum. Mutat., 21, 182-191.
5. Brooks CL and Gu W. (2003). Curr. Opin. Cell Biol., 15, 164-171.
6. Burger H, Nooter K, Boersma AW, Kortland CJ and Stoter G. (1998). Br. J. Cancer, 77, 1562-1567.
7. Burger H, Nooter K, Boersma AW, van Wingerden KE, Looijenga LH, Jochemsen AG and Stoter G. (1999). Int. J. Cancer, 81, 620-628.
8. Chaganti RS and Houldsworth J. (2000). Cancer Res., 60, 1475-1482.
9. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
10. Chresta CM, Masters JR and Hickman JA. (1996). Cancer Res., 56, 1834-1841.
11. Curtin JC, Dragnev KH, Sekula D, Christie AJ, Dmitrovsky E and Spinella MJ. (2001). Oncogene, 20, 2559-2569.
12. Einhorn LH. (2002). Chest Surg. Clin. N. Am., 12, 695-706.
13. Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F and Nervi C. (2001). Cancer Res., 61, 2-7.
14. Freemantle SJ, Kerley JC, Olsen SL, Gross RH and Spinella MJ. (2002). Oncogene, 21, 2880-2889.
15. Freemantle SJ, Spinella MJ and Dmitrovsky E. (2003). Oncogene, 22, 7305-7315.
16. Glass CK and Rosenfeld MG. (2000). Genes Dev., 14, 121-141.
17. Gu J, Rubin RM and Yuan ZM. (2001). Oncogene, 20, 3519-3527.
18. Heimdal K, Lothe RA, Lystad S, Holm R, Fossa SD and Borresen AL. (1993). Genes Chromosomes Cancer, 6, 92-97.
19. Ho J and Benchimol S. (2003). Cell Death and Differ., 10, 404-408.
20. Hoffman WH, Biade S, Zilfou JT, Chen J and Murphy M. (2002). J. Biol. Chem., 277, 3247-3257.
21. Hong WK and Sporn MB. (1997). Science, 278, 1073-1077.
22. Houldsworth J, Xiao H, Murty VV, Chen W, Ray B. Reuter VE, Bosl GJ and Chaganti RS. (1998). Oncogene, 16, 2345-2349.
23. Huyghe E, Matsuda T and Thonneau P. (2003). J. Urol., 170, 5-11.
24. Johnson RA, Ince TA and Scotto KW. (2001). J. Biol. Chem., 276, 27716-27720.
25. Johnstone RW. (2002). Nat. Rev. Drug Discov., 1, 287-299.
26. Jones RH and Vasey PA. (2003). Eur. J. Cancer, 39, 147-156.
27. Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS and Wu CW. (2000). J. Biol. Chem., 275, 20436-20443.
28. Kersemaekers AM, Mayer F, Molier M, van Weeren PC, Oosterhuis JW, Bokemeyer C and Looijenga LH. (2002). J. Clin. Oncol., 20, 1551-1561.
29. Kouraklis G and Theocharis S. (2002). Curr. Med. Chem. Anti-Canc. Agents, 2, 477-484.
30. Langenfeld J, Kiyokawa H, Sekula D, Boyle JO and Dmitrovsky E. (1997). Proc. Natl. Acad. Sci. USA, 94, 12070-12074.
31. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH and Evans RM. (1998). Nature, 391, 811-814.
32. Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA and Hong WK. (2001). J. Natl. Cancer Inst., 93, 605-618.
33. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L and Gu W. (2001). Cell, 107, 137-148.
34. Luo J, Su F, Chen D, Shiloh A and Gu W. (2000). Nature, 408, 377-381.
35. Lutzker SG and Levine AJ. (1996). Nat. Med., 2, 804-810.
36. Lutzker SG, Mathew R and Taller DR. (2001). Oncogene, 20, 2982-2986.
37. Mangelsdorf DJ, Umesono K and Evans RM. (1994). The Retinoids: Biology, Chemistry and Medicine Sporn MB, Roberts AB, Goodman DS. (eds). Raven Press, Ltd: New York, pp. 319-349.
38. Moasser MM, Khoo KS, Maerz WJ, Zelenetz A and Dmitrovsky E. (1996). Differentiation, 60, 251-257.
39. Moasser MM, Reuter VE and Dmitrovsky E. (1995). Oncogene, 10, 1537-1543.
40. Nason-Burchenal K and Dmitrovsky E. (1999). Retinoids: Handbook of Experimental Pharmacology. Nau H and Blaner WS. (eds) Springer-Verlag: Berlin, pp. 301-322.
41. Oren M. (2003). Cell Death. Differ., 10, 431-442.
42. Pandolfi PP. (2001). Oncogene, 20, 3116-3127.
43. Pavletich NP, Chambers KA and Pabo CO. (1993). Genes Dev., 7, 2556-2564.
44. Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbul M, Jewett M, Buchanan J and Goss PE. (1993). Cancer Res., 53, 3574-3578.
45. Petti MC, Fazi F, Gentile M, Diverio D, De Fabritiis P, De Propris MS, Fiorini R, Spiriti MA, Padula F, Pelicci PG, Nervi C and Lo Coco F. (2002). Blood, 100, 1065-1067.
46. Ronca F, Yee KS and Yu VC. (1999). J. Biol. Chem., 274, 18128-18134.
47. Shin DM, Mao L, Papadimitrakopoulou VM, Clayman G, El-Naggar A, Shin HJ, Lee JJ, Lee JS, Gillenwater A, Myers J, Lippman SM, Hittelman WN and Hong WK. (2000). J. Natl. Cancer. Inst., 92, 69-73.
48. Shin DM, Xu XC, Lippman SM, Lee JJ, Lee JS, Batsakis JG, Ro JY, Martin JW, Hittelman WN, Lotan R and Hong WK. (1997). Clin. Cancer Res., 3, 875-880.
49. Spinella MJ, Freemantle SJ, Sekula D, Chang JH, Christie AJ and Dmitrovsky E. (1999). J. Biol. Chem., 274, 22013-22018.
50. Spinella MJ, Kerley JS, White K and Curtin JC. (2003). J. Nutr., 133, 2738-2768.
51. Spinella MJ, Kitareewan S, Mellado B, Sekula D, Khoo KS and Dmitrovsky E. (1998). Oncogene, 16, 3471-3480.
52. Sun SY and Lotan R. (2002). Crit. Rev. Oncol. Hematol., 41, 41-55.
53. Varley J. (2003). Methods Mol. Biol., 222, 117-129.
54. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L and Weinberg RA. (2001). Cell, 107, 149-159.
55. Wadgaonkar R and Collins T. (1999). J. Biol. Chem., 274, 13760-13767.
56. Zamble DB, Jacks T and Lippard SJ. (1998). Proc. Natl. Acad. Sci. USA, 95, 6163-6168.
57. Zeng X, Keller D, Wu L and Lu H. (2000). Cancer Res., 60, 6184-6188.
58. Zhou DC, Kim SH, Ding W, Schultz C, Warrell RP and Gallagher RE. (2002). Blood, 99, 1356-1363.
59. Zilfou JT, Huffman WH, Sank M, George DL and Murphy MT. (2001). Mol. Cell Biol, 21, 3974-3985.